Elevance Health, Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $84.86B (year ended Dec 31, 2016) to $199.12B (year ended Dec 31, 2025), a compound annual growth rate of 9.9%. The fastest growth was +16.9% in the year ended Dec 31, 2020; the weakest year was +2.3% (year ended Dec 31, 2018).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $199.12B | +12.5% | Revenues | 10-K filed Feb 6, 2026 |
| Dec 31, 2024 | $177.01B | +3.3% | Revenues | 10-K filed Feb 6, 2026 |
| Dec 31, 2023 | $171.34B | +9.4% | Revenues | 10-K filed Feb 6, 2026 |
| Dec 31, 2022 | $156.59B | +13.0% | Revenues | 10-K filed Feb 20, 2025 |
| Dec 31, 2021 | $138.64B | +13.8% | Revenues | 10-K filed Feb 21, 2024 |
| Dec 31, 2020 | $121.87B | +16.9% | Revenues | 10-K filed Feb 15, 2023 |
| Dec 31, 2019 | $104.21B | +13.1% | Revenues | 10-K filed Feb 16, 2022 |
| Dec 31, 2018 | $92.11B | +2.3% | Revenues | 10-K filed Feb 18, 2021 |
| Dec 31, 2017 | $90.04B | +6.1% | Revenues | 10-K filed Feb 19, 2020 |
| Dec 31, 2016 | $84.86B | +7.2% | Revenues | 10-K filed Feb 20, 2019 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $51.43B | +1.4% | 10-Q filed Oct 21, 2026 |
| 3 months ended Jun 30, 2026 | $50.47B | +1.4% | 10-Q filed Jul 15, 2026 |
| 3 months ended Mar 31, 2026 | $50.18B | +2.6% | 10-Q filed Apr 22, 2026 |
| 3 months ended Sep 30, 2025 | $50.71B | +12.4% | 10-Q filed Oct 21, 2026 |
| 3 months ended Jun 30, 2025 | $49.78B | +13.4% | 10-Q filed Jul 15, 2026 |
| 3 months ended Mar 31, 2025 | $48.89B | +14.8% | 10-Q filed Apr 22, 2026 |
| 3 months ended Sep 30, 2024 | $45.11B | +5.3% | 10-Q filed Oct 21, 2025 |
| 3 months ended Jun 30, 2024 | $43.89B | +0.5% | 10-Q filed Jul 17, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 1156039 (raw data). Most recent filing in this dataset: 10-Q filed Oct 21, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.